312050
Reducing Global Health Inequality among Lower-income Girls: Making HPV vaccines Affordable
With the support of Médecins Sans Frontières (MSF), or Doctors Without Borders, we have undertaken original research on the manufacturing costs of Gardasil and Cevarix. With detailed documentation, we will present the results and their potential to make HPV vaccines affordable to girls in all the World Bank’s 4 income tiers at affordable, yet profitable prices. Cervical cancer can become history.
Learning Areas:
Administer health education strategies, interventions and programsImplementation of health education strategies, interventions and programs
Public health or related public policy
Systems thinking models (conceptual and theoretical models), applications related to public health
Learning Objectives:
Analyze the costs of manufacturing Gardasil and Cervarix as HPV vaccines to prevent cervical cancer
Assess the cost impact on prices for lower-middle and upper-middle, as well as upper income countries
Design policies to reduce global health inequalities for women
Keyword(s): Cancer and Women’s Health, Accessibility
Qualified on the content I am responsible for because: I am a professor of comparative health policy and expert on pharmaceutical policy
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.